Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
about
Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathyAnalysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease PrionsHuman prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice.Kuru: a journey back in time from papua new Guinea to the neanderthals' extinctionMammalian prions: tracking the infectious entitiesTransmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease PatientsSensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.Identification of I137M and other mutations that modulate incubation periods for two human prion strains.Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tauAsynchronous onset of clinical disease in BSE-infected macaques.Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USARevisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory FindingsAnalyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prionsDeciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.Prion disease: experimental models and reality.UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approachesBiochemical and strain properties of CJD prions: complexity versus simplicity.Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain.Human prion diseases: molecular, cellular and population biology.Molecular diagnosis of human prion disease.Prion disease: a tale of folds and strains.The influence of PRNP polymorphisms on human prion disease susceptibility: an update.Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases.Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions.Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
P2860
Q28534276-68670143-C5A0-4D14-B8A7-D2B7782D1C0EQ28831096-1E4ED97E-645A-4240-A386-E7502F58CF9BQ30467870-AF7644DC-D8EF-46E4-84B4-7D9C013D4010Q33925689-1A1A6BC2-554B-4B15-B35C-436837253F80Q34450227-90D228BF-320D-4AC1-8592-2E2EDB82A415Q35194912-9AF5EE00-A4CE-4945-A32E-5186DF4B29E9Q35488323-0F7F7915-9868-4924-81D0-DDF74414313EQ35913122-1C92D3D9-8FCE-4C9A-AF3E-1413D6C10551Q35960528-CEF77712-EEE5-42DE-8D51-2469F091EF1CQ36023181-5EBE9C4D-3D50-40E0-BD4B-EB213307F618Q36465091-C5F98F45-6458-4038-832C-CA3B42424CBCQ37021022-9991D7C7-6A86-40DB-A94B-DF9AA98D8B9AQ37050261-FF1964F6-FA05-4817-85F7-596F55201DFCQ37053965-A61205CC-DD6A-4EC7-9E12-04EDDDF37C5BQ37201233-6DAD55D3-5A1C-466A-B088-D8564CF1C686Q37323241-F55468A7-9D38-4FF1-B36D-B87B5A24E49DQ37448617-43F4FE29-F4AF-4D5F-B32D-ECB37ED9E456Q37596801-D2116503-0653-4DED-8D40-57C9851EC15CQ37697473-40C9C0B9-EAD4-4741-81DC-6F6279923CA5Q37905853-4D4CC966-7C90-48C4-AC69-BAA176A5B4A1Q37990996-F250CFAA-8525-4032-9559-725DFE091741Q38075119-39F44F40-8DD6-4A49-9378-CA8324B03B3BQ38088738-385CBE35-30D5-4755-A149-711A4FF8615FQ38099068-FB97D2C9-C3DF-483C-97DC-18F0659AC95DQ38507000-2C6ED682-67F7-474C-A167-11752B05D96AQ38669959-602F0290-AD34-47AC-A56E-1F67EC2A9058Q38972042-7855E942-DC24-49DF-B702-3C1734809F87Q40087612-E57D8007-3AFB-48BB-95C2-214C9E0A824FQ41635697-D61F2691-4145-4E0F-9CCB-CADC76479030Q44582815-DEA68ABF-3E0F-4C98-AFA9-F7EFC0D322B1Q47370525-3548D781-631B-42B5-9A20-88B04DA3B0E5Q48238909-E7E30E7F-19BD-4F9C-96E0-48B111FDB6BDQ48241746-018D2034-E187-4A45-BAA1-A5FA77433B2C
P2860
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Agent strain variation in huma ...... imentally transmitted disease.
@ast
Agent strain variation in huma ...... imentally transmitted disease.
@en
Agent strain variation in huma ...... imentally transmitted disease.
@nl
type
label
Agent strain variation in huma ...... imentally transmitted disease.
@ast
Agent strain variation in huma ...... imentally transmitted disease.
@en
Agent strain variation in huma ...... imentally transmitted disease.
@nl
prefLabel
Agent strain variation in huma ...... imentally transmitted disease.
@ast
Agent strain variation in huma ...... imentally transmitted disease.
@en
Agent strain variation in huma ...... imentally transmitted disease.
@nl
P2093
P2860
P356
P1433
P1476
Agent strain variation in huma ...... imentally transmitted disease.
@en
P2093
Bernardino Ghetti
Hans Kretzschmar
Maura Cescatti
Paul Brown
Sabina Capellari
Silvio Notari
Walter J Schulz-Schaeffer
Wen-Quan Zou
P2860
P304
P356
10.1093/BRAIN/AWQ234
P407
P577
2010-09-07T00:00:00Z